M1 |
IFN-γ, TNFα, IL-1β, LPS |
CD11b, CD11c, CD80, HLA-DR, IL-1β, IL-8, TNFα, IL-12 |
CD11b, F4/80, CD80, CD86, Ly6c, MHC-II, iNOS, IL-1β, IL-8, TNF-α, IL-12 |
Proinflammatory, anti-tumour |
M2a |
IL-4, IL-13 |
CD206, CD163, IL-10, TGF-β, CCL17, CCL18, CCL22, CCL24 |
CD163, Arg1, IL-10, TGF-β, CCL17, CCL18, CCL22, CCL24 |
Anti-inflammatory |
M2b |
IL-1β, LPS |
CD86, IL-10, IL-12, IL-6, TNF-α |
IL-10, IL-12, IL-6, TNF-α |
Immunoregulation, tumour progression |
M2c |
IL-10, TGF-β, glucocorticoids |
CD163, CD206, IL-10, TGF-β, |
Arg1, IL-10, TGF-β, |
Angiogenesis, phagocytosis, wound healing |
M2d |
TLR ligand, LPS, IL-6 |
IL-10, VEGF |
IL-10, VEGF |
Tumour progression, immunosuppressive, angiogenesis |